Should Protocols Specific to Histologic Subtypes Be Applied in the Follow-Up of NSCLC?
- PMID: 34561037
- DOI: 10.1016/j.jtho.2021.06.018
Should Protocols Specific to Histologic Subtypes Be Applied in the Follow-Up of NSCLC?
Comment in
-
Posttreatment Surveillance Challenges in the Era of Precision Medicine.J Thorac Oncol. 2021 Oct;16(10):e77-e78. doi: 10.1016/j.jtho.2021.07.023. J Thorac Oncol. 2021. PMID: 34561038 No abstract available.
Comment on
-
Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis.J Thorac Oncol. 2021 May;16(5):784-797. doi: 10.1016/j.jtho.2021.01.1622. Epub 2021 Feb 12. J Thorac Oncol. 2021. PMID: 33588110
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
